Skip to main content
. 2021 Jul 13;8(6):662–673. doi: 10.1093/nop/npab042

Table 3.

Topics of Discussion Between Patient/Caregiver and Physician Regarding the Risk of Developing Brain Metastases, and Topic of Information on Brain Metastases Each Group Wished They Would Like to See More of

Topic of Discussion Between Patient/Caregiver and Physician Physicians Patients Caregivers P Value for Differences by Groupa
 Overview of brain metastases 161 (67.4) 105 (44.9) 111 (53.1) <.001
 Symptoms to be aware of 191 (79.9) 112 (47.9) 123 (58.9) <.001
 Plan/schedule for testing 139 (58.2) 107 (45.7) 78 (37.3) <.001
 Where to go for information/support 66 (27.6) 99 (42.3) 78 (37.3) .003
 Survival rates 101 (42.3) 102 (43.6) 85 (40.7) .825
 Caregiver support 67 (28.0) 91 (38.9) 67 (32.1) .04
 Treatment options 157 (65.7) 118 (50.4) 107 (51.2) .001
Topic of Information You Would Like to Know More About Physicians Patients Caregivers P Value for Differences by Groupa
 Overview of brain metastases 60 (25.1) 97 (41.5) 92 (44.0) <.001
 Symptoms to be aware of 61 (25.5) 102 (43.6) 93 (44.5) <.001
 Plan/schedule for testing 57 (23.8) 87 (37.2) 56 (26.8) .004
 Where to go for information/support 68 (28.5) 101 (43.2) 94 (45.0) <.001
 Survival rates 92 (38.5) 122 (52.1) 98 (46.9) .01
 Caregiver support 80 (33.5) 87 (37.2) 89 (42.6) .138
 Treatment options 105 (43.9) 109 (46.6) 96 (45.9) .834

a P values are generated by a chi-square test.